Search Results

Asthma Mortality and Long-Acting Beta2-Agonists in Five Major European Countries, 1994-2004

Authors: Chatenoud, Liliane; Malvezzi, Matteo; Pitrelli, Andrea; La Vecchia, Carlo; Bamfi, Francesco

Source: Journal of Asthma, Volume 46, Number 6, August 2009 , pp. 546-551(6)

Publisher: Informa Healthcare

Pharmacoeconomic review of medical management of persistent asthma

Authors: Cheng, Judy W.M.; Arnold, Renée J. Goldberg

Source: Allergy and Asthma Proceedings, Volume 29, Number 2, March-April 2008 , pp. 109-122(14)

Publisher: OceanSide Publications, Inc

Part IV: Genetic variations in β₂-adrenergic receptors: long-acting and short-acting β₂-agonists and therapeutic response

Author: Peters, Stephen

Source: Current Medical Research and Opinion, Volume 23, Supplement 3, September 2007 , pp. 29-36(8)

Publisher: Informa Healthcare

The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations

Authors: Brixner, D.I.; Lenhart, G.; Young, D.C.; Samuelson, W.M.

Source: Current Medical Research and Opinion, Volume 23, Number 11, November 2007 , pp. 2887-2895(9)

Publisher: Informa Healthcare

Assessment of asthma control and its impact on optimal treatment strategy

Authors: Lundback, B.; Dahl, R.

Source: Allergy, Volume 62, Number 6, June 2007 , pp. 611-619(9)

Publisher: Blackwell Publishing

The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease

Authors: White, Andrew A.; Stevenson, Donald D.; Simon, Ronald A.

Source: Annals of Allergy, Asthma and Immunology, Volume 95, Number 4, October 2005 , pp. 330-335(6)

Publisher: American College of Allergy, Asthma, & Immunology

Safety updates for long-acting 2-agonists in the US

Source: Reactions, Volume 1, Number 1069, 2005-09-17 , pp. 3-3(1)

Publisher: Adis International

Ultra long-acting ₂-agonists in development for asthma and chronic obstructive pulmonary disease

Authors: Cazzola, Mario; Matera, Maria Gabriella; Lötvall, Jan

Source: Expert Opinion on Investigational Drugs, Volume 14, Number 7, 1 July 2005 , pp. 775-783(9)

Publisher: Informa Healthcare

Inhaled 2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease

Authors: Cazzola, Mario; Matera, Maria G.; Donner, Claudio F.

Source: Drugs, Volume 65, Number 12, 2005 , pp. 1595-1610(16)

Publisher: Adis International

Inhaled Salmeterol/Fluticasone Propionate: A Review of its Use in Asthma

Authors: Reynolds, Neil A.; Lyseng-Williamson, Katherine A.; Wiseman, Lynda R.

Source: Drugs, Volume 65, Number 12, 2005 , pp. 1715-1734(20)

Publisher: Adis International

As-Needed Inhaled 2-Adrenoceptor Agonists in Moderate-to-Severe Asthma: Current Recommendations

Author: Cockcroft, Donald W.

Source: Treatments in Respiratory Medicine, Volume 4, Number 3, 2005 , pp. 169-174(6)

Publisher: Adis International

The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease

Authors: Bonay Marcel; Bancal Catherine; Crestani Bruno

Source: Expert Opinion on Drug Safety, Volume 4, Number 2, 1 March 2005 , pp. 251-271(21)

Publisher: Informa Healthcare

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Authors: M. Humbert; R. Beasley; J. Ayres; R. Slavin; J. Hébert; J. Bousquet; K.-M. Beeh; S. Ramos; G. W. Canonica; S. Hedgecock; H. Fox; M. Blogg; K. Surrey

Source: Allergy, Volume 60, Number 3, March 2005 , pp. 309-316(8)

Publisher: Blackwell Publishing

Short-acting ₂-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting ₂-agonist or salmeterol/fluticasone propionate combination

Authors: R. Angus; R. Reagon; A. Cheesbrough

Source: International Journal of Clinical Practice, Volume 59, Number 2, February 2005 , pp. 156-162(7)

Publisher: Blackwell Publishing

Single-Dose Agents in the Prevention of Exercise-Induced Asthma: A Descriptive Review

Author: Sandra D. Anderson

Source: Treatments in Respiratory Medicine, Volume 3, Number 6, 2004 , pp. 365-379(15)

Publisher: Adis International

Combination Therapy of Long-Acting ₂-Adrenoceptor Agonists and Corticosteroids for Asthma

Authors: K. Fan Chung; Ian M. Adcock

Source: Treatments in Respiratory Medicine, Volume 3, Number 5, 2004 , pp. 279-289(11)

Publisher: Adis International

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting ₂-agonists

Authors: Murray, John; Rosenthal, Richard; Somerville, Laura; Blake, Kathryn; House, Karen; Baitinger, Leslie; VanderMeer, Anna; Dorinsky, Paul

Source: Annals of Allergy, Asthma and Immunology, Volume 93, Number 4, October 2004 , pp. 351-359(9)

Publisher: American College of Allergy, Asthma, & Immunology

Combination therapy in asthma – fixed or variable dosing in different patients?

Author: Jan Lötvall

Source: Current Medical Research and Opinion, Volume 20, Number 11, November 2004 , pp. 1711-1727(17)

Publisher: Informa Healthcare

Combination Therapy of Inhaled Corticosteroids and Long-Acting 2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease

Authors: Sin, Don D.; Johnson, Malcolm; Gan, Wen Q.; Man, S. F. P.a.u.l.

Source: Current Pharmaceutical Design, Volume 10, Number 28, November 2004 , pp. 3547-3560(14)

Publisher: Bentham Science Publishers

The place of inhaled corticosteroids in chronic obstructive pulmonary disease

Author: Selroos, Olof

Source: Current Medical Research and Opinion, Volume 20, Number 10, 1 October 2004 , pp. 1579-1593(15)

Publisher: Informa Healthcare